Stacey King
Posts: 7989
Joined: 7/21/2007
Status: offline
|
The Red Sox system on Thursday took a hit with the news that righthander Michael Kopech has been suspended 50 games for testing positive for Oxilofrine, a stimulant banned under the Minor League Drug Prevention and Treatment Program. Kopech, a supplemental first-round pick in 2014 (No. 33 overall), was 4-5, 2.63 this season with low Class A Greenville, and had struck out 70 hitters in 65 innings. He showed a fastball that touched as high as 100 mph this season, as well as an inconsistent but promising breaking ball and a nascent changeup. The suspension isn’t the first to happen to a big-name pick over the use of banned stimulants. Blue Jays righthander Marcus Stroman was docked 50 games in 2012, just months after he was drafted in the first round out of Duke, for testing positive for methylhexamine, another stimulant. The Rays, too, have had their problems with stimulant-based suspensions. Infielder Ryan Brett, who has three major league games to his credit, was suspended 50 games in 2012 after testing positive for what Major League Baseball termed “methamphetamine and an amphetamine.” Two of Brett’s teammates, pitchers Justin Woodall and Charles Colonie, were each hit with the same punishment for the same offense. Established major leaguers aren’t immune, either. Baltimore first baseman Chris Davis was suspended 25 games last year for testing positive for Adderall, and fellow Oriole Troy Patton received a similar ban in 2013, also for Adderall. The same goes for Phillies catcher Carlos Ruiz in the 2012 offseason. The catch with major leaguers is that suspensions for stimulants can’t happen until their second positive test. By coincidence, exactly 50 games remain in Greenville’s season, meaning there’s no chance Kopech would make a late-season comeback. The next time Kopech is likely to pitch will be during the fall instructional league.
|